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Abstract: Salmonella enterica infections result in diverse
clinical manifestations. Typhoid fever, caused by S.
enterica serovar Typhi (S. Typhi) and S. Paratyphi A, is a
bacteremic illness but whose clinical features differ from
other Gram-negative bacteremias. Non-typhoidal Salmo-
nella (NTS) serovars cause self-limiting diarrhea with
occasional secondary bacteremia. Primary NTS bacteremia
can occur in the immunocompromised host and infants in
sub-Saharan Africa. Recent studies on host–pathogen
interactions in Salmonellosis using genome sequencing,
murine models, and patient studies have provided new
insights. The full genome sequences of numerous S.
enterica serovars have been determined. The S. Typhi
genome, compared to that of S. Typhimurium, harbors
many inactivated or disrupted genes. This can partly
explain the different immune responses both serovars
induce upon entering their host. Similar genome degra-
dation is also observed in the ST313 S. Typhimurium strain
implicated in invasive infection in sub-Saharan Africa.
Virulence factors, most notably, type III secretion systems,
Vi antigen, lipopolysaccharide and other surface polysac-
charides, flagella, and various factors essential for the
intracellular life cycle of S. enterica have been character-
ized. Genes for these factors are commonly carried on
Salmonella Pathogenicity Islands (SPIs). Plasmids also carry
putative virulence-associated genes as well as those
responsible for antimicrobial resistance. The interaction
of Salmonella pathogen-associated molecular patterns
(PAMPs) with Toll-like receptors (TLRs) and NOD-like
receptors (NLRs) leads to inflammasome formation,
activation, and recruitment of neutrophils and macro-
phages and the production of pro-inflammatory cyto-
kines, most notably interleukin (IL)-6, IL-1b, tumor necrosis
factor (TNF)-a, and interferon-gamma (IFN)-c. The gut
microbiome may be an important modulator of this
immune response. S. Typhimurium usually causes a local
intestinal immune response, whereas S. Typhi, by
preventing neutrophil attraction resulting from activation
of TLRs, evades the local response and causes systemic
infection. Potential new therapeutic strategies may lead
from an increased understanding of infection pathogen-
esis.
Introduction
Typhoid fever is a global problem, with more than 27 million
cases worldwide each year resulting in an estimated 217,000
deaths [1]. Salmonella enterica serovar Typhi (S. Typhi) and S.
Paratyphi A are the Gram-negative bacteria that cause this
debilitating condition. It is most common among children,
especially in areas of Asia and Africa that lack clean water and
adequate sanitation, and is also an important travel-associated
disease [2]. S. Typhi is an exclusively human pathogen causing a
bacteremic disease that, unlike many other Gram-negative
bacteremias, does not typically manifest with neutrophilia or
septic shock [3]. The widespread appearance of antimicrobial-
resistant strains has limited treatment options [4,5]. Relapse and
chronic asymptomatic fecal carriage may complicate the illness
(Figure 1) [6,7]. Mortality usually results from intestinal perfora-
tion and peritonitis or from a severe toxic encephalopathy
associated with myocarditis and hemodynamic shock [8].
Infections with non-typhoidal Salmonella (NTS) serovars, such as
S. enterica serovar Typhimurium and S. Enteriditis, also cause a
significant disease burden, with an estimated 93.8 million cases
worldwide and 155,000 deaths each year (see [9] for review) [10].
NTS serovars usually cause self-limiting diarrhea with secondary
bacteremia occurring in less than 10% of patients. The host range
of non-typhoidal Salmonella serovars is broad, including poultry and
cattle, and NTS infection is commonly due to food poisoning in
developed countries. NTS serovars cause high rates of bacteremia
in the immunocompromised and, in sub-Saharan Africa, in
children below 5 years old and those with HIV infection [9,11].
Antimicrobial resistance is widespread [12].
The variations in the clinical features of infection with this
intracellular pathogen relate to differences in the interaction
between different Salmonella serovars and the host. This review
summarizes new and significant insights concerning the virulence
factors of both typhoid and non-typhoidal Salmonellae, their
difference at the genome level, novel mechanisms employed by
these intruders to circumvent the host defense, and their
interactions with both host microbiome and the innate immune
system.
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The Bacteria
Taxonomy and Genomics of Salmonella
The genus Salmonella is composed of two distinct species:
Salmonella bongori and Salmonella enterica, the latter being divided into
six subspecies. These subspecies are classified into more than 50
serogroups based on the O (somatic) antigen, and divided into
.2,400 serovars based on the H (flagellar) antigen. Complete
genome sequence from multiple Salmonella strains are available
[13]. For example, the S. Typhi type strain Ty2, the multidrug-
resistant (MDR) isolate CT18, and the S. Typhimurium strain
LT2 are composed of 4.79 (Ty2), 4.86 (CT18), and 4.81 (LT2)
megabases, respectively [14–16]. The core genomes of Escherichia
coli and S. enterica differ by only 10% in their DNA sequences and
suggest that the two species derived from a common ancestor
about 100 million years ago. Comparison of different S. Typhi
isolates show that they are highly related (clonal) and have arisen
from a single point of origin approximately 30,000–50,000 years
ago [17]. The sequence-based technique of MLST (multilocus
sequence typing) provides a more accurate indication of the
genomic relationship between different Salmonella isolates and may
supersede serotyping in the future [18]. Of the ,4,000 S. Typhi
genes, more than 200 are functionally disrupted or inactive, while
most of these homologs are still fully functional in S. Typhimur-
ium. This could in part explain the restricted host range of S.
Typhi [16]. Although it has been suggested that the different
clinical outcomes of infection between typhoid and NTS serovars
may be explained by differences in genome expression leading to
differences in host-pathogen recognition, one should also consider
the opposite possibility; that is, differences in host-pathogen
interaction may make certain genes dispensable, resulting in the
accumulation of pseudogenes [3,19,20].
Recent analysis of S. Typhimurium isolates from the unusually
invasive infections seen in sub-Saharan Africa have shown
dominance of a particular MLST type, ST313, distinct from the
usual S. Typhimurium sequence type, ST19, associated in other
Figure 1. Dissemination of S. Typhi during systemic infection. Typhoid is usually contracted by ingestion of food or water contaminated by
fecal or urinary carriers excreting S. Typhi. The incubation period is usually 7 to 14 d. In the small intestine the bacteria adhere to the mucosa and then
invade the epithelial cells. The Peyer’s patches, which are aggregrated lymphoid nodules of the terminal ileum, play an important role in the transport
to the underlying lymphoid tissue. Specialized epithelial cells such as M cells overlying these Peyer’s patches are probably the site of internalization of
S. Typhi. Once the bacteria have penetrated the mucosal barrier, the invading organism translocates to the intestinal lymphoid follicles and the
draining mesenteric lymph nodes, and some pass on to the reticuloendothelial cells of the liver and spleen. During the bacteremic phase, the bacteria
are widely disseminated throughout the body. Secondary infection can occur with liver, spleen, bone-marrow, gallbladder, and Peyer’s patches as the
most preferred sites. The gallbladder is the main reservoir during a chronic infection with S. Typhi and invasion occurs either directly from the blood
or by retrograde spread from the bile. Of interest, the ability of Salmonella to form biofilms on gallstones is likely to be a critical factor in
establishment of chronic carriage and shedding of S. Typhi [88]. The bacteria that are excreted in the bile can then reinvade the intestinal wall by the
mechanism previously described or are excreted by feces. Typical clinical symptoms are fever, malaise, and abdominal discomfort. Clinical features
such as a tender abdomen, hepatomegaly, splenomegaly, and a relative bradycardia are common. Rose spots, the classical skin lesions associated
with typhoid fever, are relatively uncommon and occur in 5%–30% of cases. The most severe manifestations of typhoid leading to sepsis and death
are either necrosis of the Peyer’s patches resulting in gut perforation and peritonitis or a toxic encephalopathy associated with myocarditis and
haemodynamic shock [8,89].
doi:10.1371/journal.ppat.1002933.g001
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parts of the world with diarrhea. In the D23580 invasive S.
Typhimurum isolate from Malawi, there is loss of gene function,
including genes previously implicated in the virulence of S.
Typhimurium in the murine model of infection, such as sseI
(encoding a type III-secreted effector protein) and ratB (encoding a
secreted protein associated with intestinal persistence), and of the
44 novel pseudogenes or deletions in the strain relative to LT2, 26
are also pseudogenes or deletions in S. Typhi or S. Paratyphi A
[21]. These observations suggest that a similar process of adaption
to the human host may be occurring in African S. Typhimurium as
has been observed in S. Typhi.
Virulence Factors
About 90% of the genes in S. Typhi and S. Typhimurium
serovars are identical [16]. The 10% of genes that differ include
virulence factors, which determine their pathogenic potential
(Figure 2) [20]. The virulence factors of the Salmonella serovars are
mostly encoded on the Salmonella pathogenicity islands (SPI).
Plasmids and prophages. Integrated bacteriophages, phage
remnants, or plasmids are single- or double-stranded DNA
molecules that can be exchanged between bacteria by horizontal
gene transfer. They give bacteria the opportunity to pass on or
receive selected genes that may enhance virulence or result in
antimicrobial resistance [17,22]. Certain Salmonella spp. have a
self-transmissible virulence plasmid called pSLT, which harbors
the spv genes. The spvB enzyme, which acts as an intracellular
ADP-ribosylating toxin causing host cytotoxicity, is necessary for
intra-macrophage survival but is absent in S. Typhi and S.
Paratyphi A [20,23]. Putative virulence-associated plasmid has
only recently been identified in S. Typhi. The chimeric plasmid
pR(ST98) carries genes that are involved in drug resistance and
apoptosis induction in macrophages [24,25]. Additionally, a linear
plasmid in S. Typhi strains originating from Indonesia, called
pBSSB1, carries the fljBz66 gene, which encodes a flagellin antigen
known as H:z66 [26]. Whether the presence of these particular
plasmids has an impact on the virulence of S. Typhi is not known.
The role of plasmids carrying antimicrobial resistance genes,
such as cat, dhfr7, dhfr14, sul1, and blaTEM-1, in the transfer and
spread of antimicrobial resistance has been well described [20,27].
S. Typhi is able to exchange multidrug resistance R-plasmids with
E. coli and other enteric bacteria [28,29]. The self-transmissible
incompatibility group (Inc)HI1 plasmids almost exclusively confer
the phenotype of MDR S. Typhi. The presence of the MDR
phenotype has been suggested to be associated with the
development of severe or fatal disease [30,31]. The presence of
a composite genetic element encoding multiple antimicrobial
resistance genes on the virulence-associated plasmid in the ST313
serovar Typhimurium isolates causing invasive disease in Africa
may provide an explanation for a linkage between drug resistance
and an invasive phenotype [21]. Prophages and phage remnants
Figure 2. Virulence of S. Typhimurium and S. Typhi. S. Typhimurium and S. Typhi possess partly overlapping and a partly distinct repertoire of
virulence factors. Both serovars express the type III secretion system, lipopolysaccharide, and other surface polysaccharides, fimbrae, flagellin, and
bacterial DNA. The Vi antigen is exclusively expressed by S. Typhi and is able to circumvent the innate immune response by repressing flagellin and
LPS expression. SPI, Salmonella pathogenicity islands.
doi:10.1371/journal.ppat.1002933.g002
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can carry non-essential ‘‘cargo’’ genes involved in bacterial
virulence including several type III secretion system effectors,
which play an important role in Salmonella virulence [20,32].
Type III secretion system and outer membrane
vesicles. Salmonella enterica spp. contains two type III secretion
system (T3SS) gene clusters encoding a secretion apparatus that
functions like a molecular syringe. The T3SS secretes effector
proteins into the target-cell cytosol, which manipulate host-cell
signaling cascades. These effector proteins are suggested to have
multiple activities within host cells; for example, SopB is involved
in invasion and Akt activation, which causes fluid secretion and
Salmonella containing vacuole (SCV) formation (Figure 3a) [33–36].
The majority of genes encoding for these virulence-associated
effector molecules are located on the SPIs. Other effector proteins
such as SopE, SspH1, SseI, SodC-1, and SopE2 are encoded by
phages or phage remnants [22,37,38].
Of the 21 SPIs known to date, SPI-1 and SPI-2 are the most
studied. S. Typhimurium and S. Typhi genomes share 11 common
SPIs; four are specific to S. Typhi (SPI-7, 15, 17, and 18) and only
one (SPI-14) for S. Typhimurium [20]. SPI-1 harbors the genes for
T3SS1, which is crucial for the invasion of non-phagocytic cells
such as M cells in the gut lumen and activation of pro-
inflammatory responses [39]. However, S. Typhimurium mutants
deficient in SPI-1 can disseminate and cause systemic infection
from the gastrointestinal tract by CD-18 expressing phagocytic
cells such as dendritic cells (DCs) without disrupting the epithelial
barrier [40,41]. Therefore, this alternative pathway via CD-18
immune cells facilitates the development of a systemic infection for
intracellular-adapted bacteria like Salmonella. T3SS2, encoded on
SPI-2, plays a crucial role during the second phase of invasion,
intracellular survival in macrophages [42]. Within the phagocyte,
T3SS2 prevents trafficking from the phagocyte NADPH oxidase
(nicotinamide adenine dinucleotide phosphate-oxidase) towards
the SCV, thereby preventing a phagocytic burst [43,44]. Although
the importance of these systems for the virulence of S.
Typhimurium is clear, limited data are available concerning the
role of T3SS in S. Typhi. Of note, the SPI-2 T3SS of S. Typhi is
not required for survival in human macrophages but may be used
during infection of other cell types, such as DCs or natural killer
cells, leading to the notion that the SPI-2 T3SS may be required to
modulate the host immune system to establish long-term
asymptomatic infection [45].
Bacterial outer membrane vesicles (OMV) have been recently
identified as another method used by Salmonella to transfer its
Figure 3. Salmonella and its first encounter with the host. (a) The intracellular life of Salmonella. Invasion of phagocytic and non-phagocytic
cells. Salmonella is a facultative intracellular pathogen that can be found in a variety of phagocytic and non-phagocytic cells, in which it is able to
survive and replicate. To establish this intracellular niche, the T3SS1 and -2 play a predominant role; key virulence factors are involved in accessing
and utilizing these cells [36]. After ingestion, intestinal colonization follows and Salmonella enters enterocytes and dendritic cells in the intestinal
epithelium [36]. Subsequently, Salmonella that reach the submucosa can be internalized by resident macrophages via different mechanisms: by
phagocytosis, active invasion using the T3SS1 or T3SS1-independent invasion using fimbriae or other adhesins on the bacterial surface. (1)
Salmonella-containing-vacuole. Following internalization Salmonella remains within a modified phagosome known as the Salmonella containing
vacuole (SCV) and injects a limited number of effector proteins, such as SipA, SipC, SopB/SigD, SodC-1, SopE2, and SptP into the cytoplasm. These
effectors cause rearrangements of the actin cytoskeleton and SCV morphology among other changes. (2) Replication within the SCV. Salmonella
survives and replicates within the SCV, where it is able to avoid host antimicrobial effector mechanisms. The T3SS2 is required for systemic virulence
in the mouse and survival within macrophages. (3) Transport of Salmonella to distant sites. After penetration of the M cells, the invading
microorganisms translocate to the intestinal lymphoid follicles and the draining mesenteric lymph nodes, and some pass on to the
reticuloendothelial cells of the liver and spleen. Salmonella organisms are able to survive and multiply within the mononuclear phagocytic cells
of the lymphoid follicles, liver, and spleen [36]. (b) Host–pathogen interaction in typhoid and non-typhoid Salmonella. Simplified scheme of the first
encounter between Salmonella spp. and the immune system. Specified cells such as neutrophils, macrophages, dendritic, phagocytic, and epithelial
cells recognize specific pathogen associated molecular patterns (PAMPs) and danger-associated-molecular patterns (DAMPs), thereby eliciting an
immune response. PAMPs such as LPS, Flagella, and bacterial DNA can trigger TRL4, TRL5, and TRL9, respectively. TLR-induced activation of NF-kB is
essential for the production of pro-IL-1b, pro-IL-18, which can be negatively regulated by IRAK-M [90]. The NLRs are situated in the cytosol and can
also recognize PAMPs. However, NLRP3 is triggered by a different, yet unknown, mechanism, although DAMPs are thought to play a crucial role. TLR,
toll-like receptors; LPS, lipopolysaccharide; NF-kB, regulated nuclear factor kappa-light-chain-enhancer of activated B cells; IRAK-M, IL-1R-assiociated
kinase-M; IL, Interleukin; ASC, apoptotic speck protein containing a caspase recruitment domain; NLR, NOD-like receptors (including NLRP3 and
NLRC4); MyD88, myeloid differentiation primary response gene [88].
doi:10.1371/journal.ppat.1002933.g003
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virulence factors into the cytoplasm of the host cell [46]. For
example, S. Typhi uses the OMV to enclose ClyA, a pore-forming
cytotoxin, and subsequently release this virulence factor extra-
cellulary [47]. Moreover, it has also been shown that OMVs can
stimulate responses important for the activation of DCs, priming
Salmonella-specific T and B cells, and possess pro-inflammatory and
antigenic function, which makes them therefore attractive as
vaccine candidates [48].
Fimbrae and flagella. Fimbriae or pili are found on the
bacterial surface and are thought to be mainly important for
biofilm formation, colonization, and initial attachment to the host
cells, although little is known about their true virulence potential
[20,36]. Each Salmonella serovar harbors a unique combination of
fimbrial operons. Flagella are long helical filaments attached to
rotary motors embedded within the membrane that enable
Salmonella species to travel to the epithelial barrier after ingestion.
In vitro, flagellin causes upregulation of pro-inflammatory
cytokines in tissue culture models [49]. However, in vivo data
showed that the role of flagella in virulence can be dispensable and
model-dependent [50–52].
Polysaccharides and other putative virulence factors. The
polysaccharidic capsule Vi antigen is of key importance for S.
Typhi virulence, but notably absent in S. Typhimurium, S.
Paratyphi A, and most other Salmonella serovars. Its presence
increases infectivity of S. Typhi and disease severity, and natural
infection is usually associated with the expression of Vi antigen in
isolated S. Typhi [53]. However, Vi negative mutants are still
able to cause a typhoid-like illness in human volunteers [54]. Two
widely separated chromosomal regions, ViaA together with ViaB,
located on SPI-7, are needed for Vi synthesis [55]. Recently it has
been hypothesized that the Vi capsule can prevent host-pathogen
recognition by preventing lipopolysaccharide (LPS) recognition
by pattern recognition receptors (PRRs) [56]. In this way S.
Typhi does not elicit a neutrophil influx in the small bowel but is
able to disseminate systemically and lead to a persistent bacterial
infection [3]. Other well-documented virulence factors include
ion transporters and superoxide-dismutases [36].
The Host Defense
PRRs, most notably the Toll-like receptors (TLR) and NOD-
like receptors (NLR), are the first component of the immune
system to detect host invasion by pathogens, initiate immune
responses, and form the crucial link between innate and adaptive
immunity [57,58]. PRRs recognize conserved motifs on pathogens
termed ‘‘pathogen-associated-molecular-patterns’’ (PAMPs) and
are also able to recognize endogenous danger signals or ‘‘danger-
associated molecular-patterns’’ (DAMPs). During invasive Salmo-
nella infection, PAMPs and DAMPs initiate the innate immune
system leading to activation and recruitment of neutrophils and
macrophages and the production of pro-inflammatory cytokines,
most notably Interleukin (IL)-6, IL-1b, tumor necrosis factor
(TNF)-a, and interferon-gamma (IFN)-c (Figure 3b) [59–65]. IFN-
c plays a central role in the control of persistent infection by
affecting the extent of macrophage activation [64]. IL-18 is
important for IFN-c release and early host resistance to Salmonella
infections [66].
During severe bacterial infection uncontrolled activation of the
innate immune response can lead to detrimental systemic
inflammation, intravascular coagulation, tissue injury, and even-
tually death [67,68]. This hyper pro-inflammatory response is only
seen to a limited extent in patients with typhoid fever. Coagulation
abnormalities do not become clinically apparent and serum levels
of TNF-a and IL-1b are low compared to the levels measured in
patients with systemic infections caused by other Gram-negative
bacteria [60,62]. Patients with typhoid fever demonstrate a
distinct and highly reproducible signature in the peripheral blood,
shown by micro-arrays and transcriptional profiling, that changes
during treatment and convalescence, returning in the majority of
cases to a normal profile as measured in healthy uninfected
controls [63]. Patients who do return to a normal profile may be
genetically or temporarily incapable of developing an effective
immune response and may be more susceptible to re-infection,
relapse, or the establishment of a carrier state [63]. In this respect
it is of importance to note that antimicrobial treatment—which
can lead to depletion of the gut microbiome—is associated with
prolonged deleterious effects on intestinal Salmonella colonization
resistance, which can result in increased fecal shedding and
carrier status (Box 1) [69]. In contrast to NTS, which is an
important cause of morbidity and mortality in patients with an
inherited or acquired immunodeficiency syndrome such as HIV
infection, IL-12R deficiency, or chronic granulomatous disease,
typhoid fever has not been associated with any primary or
acquired immunodeficiency or underlying disease [9,70,71]. Such
a difference can potentially be ascribed to a difference in
signaling through PRRs where production of interleukin-17-
producing T cells and their associated family cytokines (IL-17,
-21, -22, -26) play an important role in the dissemination of NTS
but not S. Typhi [9].
Pattern Recognition Receptors
Salmonella spp. expresses multiple PAMPs, most notably T3SS,
flagella, fimbrae, LPS (Vi antigen), and bacterial DNA, which are
recognized by PRRs (Figure 2). Not surprisingly, TLR4 plays an
important role in invasive Salmonellosis. TLR4-deficient mice
Box 1. Salmonella and the Gut Microbiome
In recent years it has become clear that the intestinal
microbiome, consisting of more bacteria than the total
number of cells in the human body, can be seen as an
exteriorised organ that exerts numerous functions in the
host response against Salmonellosis. The gut hosts
,161014 bacteria from 500–1,000 different species of
which three bacterial divisions—the Firmicutes (Gram-
positive), Bacteroides (Gram-negative), and Actinobacteria
(Gram-positive)—dominate. The healthy gut microbiome
can protect against epithelial cell injury by producing toxic
metabolites known to repress Salmonella virulence gene
expression, optimizes host immune systems, and mediates
pathogen clearance from the gut lumen after non-
typhoidal Salmonella diarrhea [69,91]. Of importance,
antimicrobial treatment depletes the gut microbiome
and is associated with prolonged deleterious effects on
intestinal Salmonella colonization resistance, which can
result in increased fecal shedding and carrier status
induction [69,92,93]. Ingeniously, S. Typhimurium is able
to exploit a specific microbiome-derived nutrient, named
ethanolamine, in order to acquire a significant growth
advantage in the lumen of inflamed intestine over other
potential pathogens [94]. Similarly, S. Typhimurium viru-
lence factors have been found to induce host-driven
production of a new electron acceptor that allows the
pathogen to use respiration to compete with fermenting
gut microbes [95]. The potential of microbiota-based
therapies for curing Salmonella-infected patients has
opened a whole new area of research [69].
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have increased susceptibility to Salmonella infection, and stimula-
tion of TLR4 by LPS has an important role in the development of
septic shock during S. Typhimurium infection [56,72–74].
Salmonella flagellin leads to TLR5 activation [49]. Intriguingly,
the Vi capsule expressed in mutated S. Typhimurium prevents
both in vitro and in vivo recognition of Salmonella LPS by TLR4
[50,56]. The presence of the Vi antigen on the cell surface leads to
capsule formation, which ultimately prevents this recognition. A
crucial role is ascribed to the TviA regulatory protein, encoded on
the S. Typhi–specific SPI-7 (viaB locus), which downregulates
flagellin production and enhances Vi antigen attachment to the
cell surface [75]. The TviA protein therefore serves as a regulatory
switch affecting the ability of the host to recognize S. Typhi as an
intruder at crucial stages of the spread in humans.
The inflammasomes, which are intracellular complexes consist-
ing of caspase-1, NLRs (e.g., NLRP3- or NLRC4), and the
adaptor molecule ASC (apoptosis-associated speck-like protein
containing a CARD), play a central role in the innate immune
defense against S. Typhimurium [76]. Mice deficient in caspase-1
or the end product of inflammasome activation, namely IL-1b and
IL-18, have higher bacterial load and succumb earlier upon
infection with S. Typhimurium [77]. In vitro experiments have
shown that S. Typhimurium induces caspase-1 and NLRC4-
dependent IL-1b release and cell death [78]. NLRC4 is able to
recognize bacterial flagellin that—as has been hypothesized by
different authors—can be injected accidentally into the cytoplasm
by the T3SS causing cytosolic perturbations [65,79–81]. However,
during experimental infection mice deficient in NLRC4 are able to
clear S. Typhimurium just as efficiently as control mice, suggesting
the involvement of other inflammasomes [78]. Indeed, Broz et al.
demonstrated that both NLRP3 and NLRC4 activate caspase-1 in
response to S. Typhimurium infection, and mice lacking both NLRP3
and NLRC4 genes show increased susceptibility to infection. In
response to a bacterial trigger, NLRP3 and NLRC4 will recruit ASC
and caspase-1 into a single cytoplasmic focus, which subsequently
serves as the site for pro-IL-1b processing [82]. Recent work provides
evidence that the recognition of bacterial flagellin by the NLRC4
inflammasome in splenic dendritic cells triggers rapid release of IL-
18, which leads to IFN-c production by memory CD8+ T cells [65].
NLRC4-mediated release of IL-1b has also been shown to be flagellin
dependent, while the bacterial trigger for NLRP3 remains unclear.
However, NLRP3 is able to recognize SPI-2 T3SS mutants, which
lack the capacity to replicate intracellularly; therefore, the receptor is
thought to play a role in the detection of persistent bacteria [83].
Although these studies underscore the central role of the inflamma-
some during S. Typhimurium infection, further research is needed to
define its role in typhoid fever [83].
Box 2. Mouse Models for S. Typhi Infection
S. Typhi infects humans exclusively. The consequent lack of
animal models has hampered the study of host–pathogen
interactions in typhoid fever. To overcome this problem
experimental murine S. Typhimurium infection has been
used extensively as a model for typhoid fever. The
intestinal pathology and inflammatory response seen in
this model resembles the changes observed in patients
with typhoid fever [96]. Current murine models include
both oral and systemic (intravenous or intraperitoneal)
inoculation with or without streptomycin pretreatment
[91]. Infection of susceptible mouse strains that carry a
mutation in the gene encoding for a metal transporter
present on the SCV membrane named Nramp1 (Slc11a1),
such as CL57/BL6 or BALB/C mice, produces a disease that
resembles typhoid fever upon inoculation with S. Typhi-
murium [20]. To study chronic and persistent infection
such as can be seen in S. Typhi carriers, strains of mice
possessing the Nramp +/+ allele, which are consequently
resistant to the infection with S. Typhimurium, are used
[64]. Of note, no allelic association was identified in
humans between the Nramp alleles and typhoid suscep-
tibility, and as S. Typhimurium causes a different disease in
humans than S. Typhi, conclusions regarding typhoid fever
pathogenesis derived from animal experiments must be
interpreted carefully [97]. An ingenious mouse model for S.
Typhi was proposed by making use of immunodeficient
Rag22/2 yc2/2 mice engrafted with human fetal liver
hematopoietic stem and progenitor cells creating human-
ized mice susceptible to S. Typhi [98]. Although these
humanized mice were able to support S. Typhi replication
and persistent infection, it did not lead to an acute lethal
infection [98]. Most recently, another murine lethal S. Typhi
model resembling characteristic features of human ty-
phoid fever was created by making use of humanized
nonobese diabetic-scid IL2rcnull mice, which are engrafted
with human hematopoetic stem cells (hu-SRC-SCID mice).
This model, which has already been proven to be useful for
detecting new virulence determinants, could also be useful
to study host–pathogen interactions and evaluate vaccine
candidates [99].
Box 3. Questions for Future Research
Genomics
N Can bacterial genotype be linked to the clinical disease
phenotype in humans?
N Is there a true association between bacterial genotype
and/or the presence of a multidrug resistant plasmid and
disease severity? If there is an association, what is the
mechanism?
Host-response
N Is there a difference between S. Typhi- and S. Paratyphi-
induced enteric fever in the host gene expression
pathways?
N What is the role of DAMPs during severe typhoid fever?
Are these danger-associated molecular patterns causing
the damage that occurs in the gut, or are they mere
bystanders triggering the NLRP3 inflammasome?
N Is a change in gut flora the reason that typhoid patients
still have an altered immune profile nine months after
infection? Moreover, do these patients have an increased
risk for re-infection with other invasive Salmonellae?
Treatment
N Can we exploit a better understanding of disease
pathogenesis to lead to new therapeutic approaches?
Potential immunomodulating treatment strategies for
invasive Salmonellosis could target the pathogen
directly (e.g., based on drugs targeting T3SS or flagella)
or target key host response proteins (e.g., TLR4, NLRC4,
or IL-1b) depending on the phase of the immune
response.
N Are steroids beneficial in severe typhoid fever as has
previously been suggested [100]? And if so, what is the
mechanism behind these observations?
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Apoptosis and Pyroptosis
Apoptosis or programmed cell death is regarded as a protective
mechanism of host defense by preventing further release of pro-
inflammatory cellular mediators [84]. Serovars of S. enterica are
able to employ different mechanisms to induce macrophage cell
death [85,86]. Recently it has been proposed that activation of
caspase-1 can also trigger a form of pro-inflammatory cell death
called ‘‘pyroptosis’’ [87]. Caspase-1, which is triggered via the
flagellin-detection of the NRLC4-inflammasome, is able to cause
clearance of S. Typhimurium independent of IL-1b or IL-18 by
pyroptotic macrophage death [76]. In infected cells, caspase-1-
induced lysis of macrophages can result in the release of bacteria
into the extracellular space, which will enable efficient reactive
oxygen species (ROS) mediated killing by neutrophils. During the
systemic phase of infection, S. Typhimurium is able to completely
suppress flagellin expression, which results in evasion of NLRC4
detection and subsequent pyroptosis [76]. Interestingly selected
Salmonella-infected caspase-1-deficient macrophages do not under-
go pyroptosis but display a form of delayed cell death with features
of autophagy [86].
Conclusion
Significant progress has been made in our understanding of
host–pathogen interactions in invasive Salmonellosis. Mouse
models using S. Typhimurium have been instrumental in
unraveling complex pathways and have shed new light on the
role of key virulence factors such as Vi antigen and T3SS (Box 2).
Studies of genome differences between S. Typhi, S. Paratyphi A, S.
Typhimurium, and other Salmonella serovars have begun to explain
some of the variation in disease manifestations. The important yet
undefined roles of DAMPs and NLR-recognition in typhoid fever
remain to be clarified, and these may be major players in the
severe gut ulceration that is an important cause of the mortality.
Despite these major advances, large gaps remain in our
understanding of the pathogenesis of the disease in humans.
Unraveling of the pathogenesis of invasive Salmonellosis hopefully
leads to new therapeutic treatment strategies, urgently needed in
the light of growing antimicrobial resistance. Box 3 summarizes
some important questions for future research on invasive Salmonella
pathogenesis research.
Search Strategy and Selection Criteria
Data for this review were identified by searches of PubMed,
with the search terms ‘‘Typhoid Fever’’ in combination with
‘‘epidemiology,’’ ‘‘clinical features,’’ ‘‘therapy,’’ and ‘‘origin.’’
‘‘Salmonella Typhi’’ or ‘‘Salmonella Typhimurium’’ in combina-
tion with ‘‘genome,’’ ‘‘virulence factors,’’ ‘‘toll-like receptors,’’
‘‘NOD-like receptors,’’ and ‘‘inflammasome.’’ The references of
identified articles were manually searched for further relevant
papers, and we also searched our own reference databases. English
and French papers were reviewed.
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